Teleflex price target raised to $170 from $165 at BofA
BofA analyst Travis Steed raised the firm’s price target on Teleflex (TFX) to $170 from $165 and keeps a Buy rating on the shares. Medical technology investor sentiment is “slightly
4d agoTFX
Compare Stocks
Compare up to 40 stocks
Compared Stocks: 1 / 40
Comparison Results
| Name | Sector | Price | Volume | Market Cap | P/E Ratio | Dividend Yield | Analyst Consensus | Analyst Price Target | Smart Score | Leveraged ETF | Article | Follow |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
 TFX | Healthcare | $155.10 | 836.40K | $6.20B | 18.47 | 0.89% | Moderate Buy |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| TFX | Teleflex | 155.10 | 48.95 | 46.11% |
| Name | Price | % Change | |
|---|---|---|---|
| TFX | $155.10 | +46.11% |
Custom Stock Latest News
Teleflex price target raised to $167 from $142 at TruistTruist raised the firm’s price target on Teleflex (TFX) to $167 from $142 and keeps a Hold rating on the shares. The company delivered small top-line upside as the management
4d agoTFX
Teleflex price target raised to $165 from $158 at BofABofA analyst Travis Steed raised the firm’s price target on Teleflex (TFX) to $165 from $158 and keeps a Buy rating on the shares. The firm views the company’s Q3
6d agoTFX
Teleflex price target raised to $165 from $155 at Raymond JamesRaymond James raised the firm’s price target on Teleflex (TFX) to $165 from $155 and keeps an Outperform rating on the shares. Teleflex delivered encouraging results with modest revenue upside
1w agoTFX- Teleflex price target raised to $160 from $140 at Mizuho
Mizuho raised the firm’s price target on Teleflex (TFX) to $160 from $140 and keeps a Neutral rating on the shares. Published first on TheFly – the ultimate source for
1w agoTFX 
Teleflex price target raised to $175 from $155 at RBC CapitalRBC Capital raised the firm’s price target on Teleflex (TFX) to $175 from $155 and keeps an Outperform rating on the shares. Published first on TheFly – the ultimate source
1w agoTFX
Teleflex Reports Third-Quarter Revenue Growth and Higher EarningsTeleflex ( ($TFX) ) has provided an update. Teleflex reported on November 5, 2026, that third-quarter revenue from continuing operations was $567.8 million, up 0.2% year over year and 3.0%
Teleflex reports Q3 adjusted EPS $2.63, consensus $1.89Reports Q3 revenue $567.8M, consensus $565.36M. “We are pleased with our third quarter performance, which included margin expansion and robust earnings per share growth, even when excluding IEEPA tariff refunds,”
1w agoTFX- Teleflex raises 2026 adjusted EPS view to $7.50-$7.75 from $6.90-$7.20
2026 EPS consensus $7.08. Lowers 2026 revenue growth view to 13.2%-14.2% from 13.4%-14.4% from 2025 revenue of $1.98B, consensus $2.27B. Published first on TheFly – the ultimate source for real-time,
1w agoTFX - Teleflex announces FDA Breakthrough Device Designation for Freesolve RMS
Teleflex (TFX) announced that the U.S. FDA has granted Breakthrough Device Designation for its Freesolve Resorbable Magnesium Scaffold for percutaneous coronary intervention. To qualify for a BDD, device technology must
3w agoTFX
Recent Analysts Ratings of Custom Stocks
| Name | Analyst | Analyst Firm | Rating | Analyst Price Target | Action | Date |
|---|---|---|---|---|---|---|
| TFX | hold | Reiterated | Nov 9, 2026 | |||
| TFX | buy | Reiterated | Nov 6, 2026 | |||
| TFX | hold | Reiterated | Nov 6, 2026 | |||
| TFX | buy | Reiterated | Nov 6, 2026 | |||
| TFX | buy | Reiterated | Nov 6, 2026 | |||
| TFX | buy | Reiterated | Nov 5, 2026 | |||
| TFX | buy | Reiterated | Sep 18, 2026 | |||
| TFX | buy | Assigned | Aug 25, 2026 | |||
| TFX | hold | Reiterated | Aug 11, 2026 |
Most Recent Earnings of Custom Stocks
| Name | Upcoming Earnings Date | Market Cap | EPS Forecast | Sales Forecast | PEG Ratio | P/E Ratio |
|---|---|---|---|---|---|---|
| TFX | Feb 25, 2027TBA | $6.20B | $1.94 | $577.93M | 0.00 | 18.47 |
Compare Stocks Side-by-Side
Our stock comparison tool allows investors to compare multiple stocks simultaneously, providing comprehensive insights into key metrics, financial data, and analyst ratings. Make informed investment decisions by analyzing stocks side by side.
Key Features of Our Stock Comparison
- Comprehensive Analysis: Compare up to 40 stocks with detailed metrics including price, market cap, P/E ratio, dividend yield, and more.
- Analyst Ratings: View consensus ratings from top Wall Street analysts and their price targets for each stock.
- Performance Tracking: Analyze historical performance with interactive charts showing 3-month, 6-month, 1-year, YTD, 3-year, and 5-year returns.
- Dividend Information: Evaluate dividend yield, payout ratio, and dividend growth for income-focused investors.
- Earnings Data: Compare earnings per share (EPS), revenue growth, and profitability metrics across companies.
How to Use the Stock Comparison Tool
Simply enter the ticker symbols of the stocks you want to compare in the search box above. You can add up to 40 stocks at once. The tool will automatically populate comparison tables with the latest data, allowing you to analyze and contrast different investment opportunities across various sectors and industries.
Popular Stock Comparisons
Investors frequently compare stocks within the same sector to identify the best investment opportunities. Popular comparisons include tech giants like Apple (AAPL) vs. Microsoft (MSFT), semiconductor leaders Nvidia (NVDA) vs. AMD, beverage companies Coca-Cola (KO) vs. Pepsi (PEP), and electric vehicle makers Tesla (TSLA) vs. Rivian (RIVN).
Why Compare Stocks?
Comparing stocks helps investors identify which companies offer the best value, growth potential, and risk-adjusted returns. By analyzing multiple stocks side by side, you can better understand relative valuations, competitive advantages, and market positioning before making investment decisions.
All Stock Comparison Categories
Custom Stock - FAQ
Which Custom stocks have a "Strong Buy" analyst rating?
None of the selected stocks have a “Strong Buy” analyst rating consensus.
Are Custom stocks overpriced?
Teleflex's stock price is currently $155.10, and its average 12-month price target is N/A.
Which Custom stocks pay dividends?
Teleflex currently pays a dividend of $0.34 which represents an annual dividend yield of 0.89%. Teleflex's next Ex-dividend date is 16 November 2026 and its next payout date is 31 December 2026.